There is new research happening at Roswell Park Comprehensive Cancer Center to see if CAR T-cell therapy that has worked for ...
CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine ...
A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in ...
Smithsonian Magazine on MSN
In a first, this personalized cell therapy treated three life-threatening autoimmune diseases in one patient
A personalized therapy involving re-engineered cells has brought phenomenal results for a woman with a rare trio of ...
The National Institute for Health and Care Excellence (NICE) has approved a chimeric antigen receptor (CAR) T-cell therapy for adults with large B-cell lymphoma. The treatment significantly delays ...
I f your doctor has recommended chimeric antigen receptor (CAR) T-cell immunotherapy for large B-cell lymphoma (LBCL), you’ve likely already tried several standard treatments, and the cancer did not ...
Pharmaceutical Technology on MSN
The innovators working to make in vivo cell therapy a reality
As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial ...
A new treatment option for certain patients with blood cancers has passed muster with the European Commission (EC). Zemcelpro, made by ExCellThera subsidiary Cordex Biologics, is a one-time cell ...
A few transplant patients in a small study were able to stop using immunosuppressive drugs, thanks to pre-transplant cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results